TreeWAS – Variant ID: rs10097215

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N42.9 Disorder of prostate, unspecified	0.030	0.970	0.000
L57.0 Actinic keratosis	0.000	0.977	0.023
R03.1 Nonspecific low blood-pressure reading	0.014	0.986	0.000
N42 Other disorders of prostate	0.011	0.989	0.000
M79.65 Pain in limb (Pelvic region and thigh)	0.000	0.989	0.011
N42.1 Congestion and haemorrhage of prostate	0.010	0.990	0.000
N42.0 Calculus of prostate	0.008	0.992	0.000
N42.3 Dysplasia of prostate	0.008	0.992	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.000	0.992	0.008
C54.1 Endometrium	0.008	0.992	0.000
N42.2 Atrophy of prostate	0.007	0.993	0.000
J15.1 Pneumonia due to Pseudomonas	0.007	0.993	0.000
C25.9 Pancreas, unspecified	0.007	0.993	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.000	0.994	0.006
L57.5 Actinic granuloma	0.000	0.994	0.006
L57.3 Poikiloderma of Civatte	0.000	0.994	0.006
L57.2 Cutis rhomboidalis nuchae	0.000	0.994	0.006
L57.1 Actinic reticuloid	0.000	0.994	0.006
C25 Malignant neoplasm of pancreas	0.006	0.994	0.000
L57.4 Cutis laxa senilis	0.000	0.994	0.005
C25.0 Head of pancreas	0.005	0.995	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.005	0.995	0.000
F31 Bipolar affective disorder	0.005	0.995	0.000
J15.2 Pneumonia due to staphylococcus	0.005	0.995	0.000
J15 Bacterial pneumonia, not elsewhere classified	0.005	0.995	0.000
F31.9 Bipolar affective disorder, unspecified	0.005	0.995	0.000
C25.8 Overlapping lesion of pancreas	0.005	0.995	0.000
C25.3 Pancreatic duct	0.005	0.995	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.005	0.995	0.000
C25.2 Tail of pancreas	0.005	0.995	0.000
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.005	0.995	0.000
T51.0 Ethanol	0.000	0.995	0.005
N42.8 Other specified disorders of prostate	0.004	0.995	0.000
D68.5 Primary Thrombophilia	0.004	0.995	0.000
C25.7 Other parts of pancreas	0.004	0.996	0.000
C25.4 Endocrine pancreas	0.004	0.996	0.000
C25.1 Body of pancreas	0.004	0.996	0.000
K61.3 Ischiorectal abscess	0.004	0.996	0.000
D68.2 Hereditary deficiency of other clotting factors	0.004	0.996	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.004	0.996	0.000
J15.8 Other bacterial pneumonia	0.004	0.996	0.000
K60.1 Chronic anal fissure	0.004	0.996	0.000
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.004	0.996	0.000
J15.4 Pneumonia due to other streptococci	0.004	0.996	0.000
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.004	0.996	0.000
F31.8 Other bipolar affective disorders	0.004	0.996	0.000
F31.7 Bipolar affective disorder, currently in remission	0.004	0.996	0.000
D68 Other coagulation defects	0.004	0.996	0.000
D68.9 Coagulation defect, unspecified	0.004	0.996	0.000
J15.9 Bacterial pneumonia, unspecified	0.004	0.996	0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.004	0.996	0.000
J15.5 Pneumonia due to Escherichia coli	0.004	0.996	0.000
J15.3 Pneumonia due to streptococcus, group B	0.004	0.996	0.000
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.000	0.996	0.004
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.004	0.996	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.004	0.996	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.004	0.996	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.996	0.004
K29.0 Acute haemorrhagic gastritis	0.004	0.996	0.000
Z99.3 Dependence on wheelchair	0.004	0.996	0.000
D35.0 Adrenal gland	0.004	0.996	0.000
C54 Malignant neoplasm of corpus uteri	0.003	0.996	0.000
T51 Toxic effect of alcohol	0.000	0.996	0.003
T51.9 Alcohol, unspecified	0.000	0.997	0.003
D68.0 Von Willebrand's disease	0.003	0.997	0.000
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.003	0.997	0.000
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.000	0.997	0.003
D68.4 Acquired coagulation factor deficiency	0.003	0.997	0.000
D68.1 Hereditary factor XI deficiency	0.003	0.997	0.000
E05.9 Thyrotoxicosis, unspecified	0.000	0.997	0.003
S02.20 Fracture of nasal bones (closed)	0.000	0.997	0.003
D32.0 Cerebral meninges	0.003	0.997	0.000
D35.1 Parathyroid gland	0.003	0.997	0.000
N32.9 Bladder disorder, unspecified	0.003	0.997	0.000
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.997	0.003
R03 Abnormal blood-pressure reading, without diagnosis	0.003	0.997	0.000
M25.06 Haemarthrosis (Lower leg)	0.003	0.997	0.000
F33 Recurrent depressive disorder	0.003	0.997	0.000
F33.0 Recurrent depressive disorder, current episode mild	0.003	0.997	0.000
C54.9 Corpus uteri, unspecified	0.003	0.997	0.000
C54.8 Overlapping lesion of corpus uteri	0.003	0.997	0.000
C54.3 Fundus uteri	0.003	0.997	0.000
C54.2 Myometrium	0.003	0.997	0.000
C54.0 Isthmus uteri	0.003	0.997	0.000
T51.8 Other alcohols	0.000	0.997	0.003
T51.3 Fusel oil	0.000	0.997	0.003
T51.2 2-Propanol	0.000	0.997	0.003
T51.1 Methanol	0.000	0.997	0.003
D68.6 Other Thrombophilia	0.003	0.997	0.000
Z80.3 Family history of malignant neoplasm of breast	0.000	0.997	0.003
F33.1 Recurrent depressive disorder, current episode moderate	0.003	0.997	0.000
H66.9 Otitis media, unspecified	0.000	0.997	0.003
F30-F39 Mood [affective] disorders	0.003	0.997	0.000
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.000	0.997	0.002
L58 Radiodermatitis	0.000	0.997	0.002
L55 Sunburn	0.000	0.997	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.003	0.997	0.000
D86.0 Sarcoidosis of lung	0.000	0.997	0.003
D68.8 Other specified coagulation defects	0.002	0.997	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.003	0.997	0.000
K83.8 Other specified diseases of biliary tract	0.000	0.997	0.002
F39 Unspecified mood [affective] disorder	0.002	0.997	0.000
L56 Other acute skin changes due to ultraviolet radiation	0.000	0.997	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
H04 Disorders of lachrymal system	0.000	0.998	0.002
F33.9 Recurrent depressive disorder, unspecified	0.002	0.998	0.000
F33.8 Other recurrent depressive disorders	0.002	0.998	0.000
F33.4 Recurrent depressive disorder, currently in remission	0.002	0.998	0.000
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.998	0.002
S60.8 Other superficial injuries of wrist and hand	0.000	0.998	0.002
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
H04.4 Chronic inflammation of lachrymal passages	0.000	0.998	0.002
F38 Other mood [affective] disorders	0.002	0.998	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.998	0.002
S72.40 Fracture of lower end of femur (closed)	0.000	0.998	0.002
G82.5 Tetraplegia, unspecified	0.002	0.998	0.000
H04.2 Epiphora	0.000	0.998	0.002
L55.9 Sunburn, unspecified	0.000	0.998	0.002
L55.8 Other sunburn	0.000	0.998	0.002
L55.2 Sunburn of third degree	0.000	0.998	0.002
L55.1 Sunburn of second degree	0.000	0.998	0.002
L55.0 Sunburn of first degree	0.000	0.998	0.002
L58.9 Radiodermatitis, unspecified	0.000	0.998	0.002
L58.1 Chronic radiodermatitis	0.000	0.998	0.002
L58.0 Acute radiodermatitis	0.000	0.998	0.002
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.000	0.998	0.002
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.000	0.998	0.002
L59.0 Erythema ab igne [dermatitis ab igne]	0.000	0.998	0.002
W18.3 Sports and athletics area	0.002	0.998	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.998	0.002
Y40 Systemic antibiotics	0.002	0.998	0.000
D86 Sarcoidosis	0.000	0.998	0.002
H04.9 Disorder of lachrymal system, unspecified	0.000	0.998	0.002
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.000	0.998	0.002
L56.4 Polymorphous light eruption	0.000	0.998	0.002
L56.3 Solar urticaria	0.000	0.998	0.002
L56.2 Photocontact dermatitis [berloque dermatitis]	0.000	0.998	0.002
L56.1 Drug photoallergic response	0.000	0.998	0.002
L56.0 Drug phototoxic response	0.000	0.998	0.002
M22.4 Chondromalacia patellae	0.002	0.998	0.000
F34 Persistent mood [affective] disorders	0.002	0.998	0.000
F30 Manic episode	0.002	0.998	0.000
H04.6 Other changes in lachrymal passages	0.000	0.998	0.002
H04.0 Dacryoadenitis	0.000	0.998	0.002
Y44.2 Anticoagulants	0.002	0.998	0.000
Z09.8 Follow-up examination after other treatment for other conditions	0.002	0.998	0.000
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.000	0.998	0.002
D35.9 Endocrine gland, unspecified	0.002	0.998	0.000
D35.8 Pluriglandular involvement	0.002	0.998	0.000
D35.7 Other specified endocrine glands	0.002	0.998	0.000
D35.6 Aortic body and other paraganglia	0.002	0.998	0.000
D35.5 Carotid body	0.002	0.998	0.000
D35.4 Pineal gland	0.002	0.998	0.000
D35.3 Craniopharyngeal duct	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
D66 Hereditary factor VIII deficiency	0.002	0.998	0.000
H04.8 Other disorders of lachrymal system	0.000	0.998	0.002
F38.8 Other specified mood [affective] disorders	0.002	0.998	0.000
F38.1 Other recurrent mood [affective] disorders	0.002	0.998	0.000
F38.0 Other single mood [affective] disorders	0.002	0.998	0.000
D86.1 Sarcoidosis of lymph nodes	0.000	0.998	0.002
N92.4 Excessive bleeding in the premenopausal period	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.002	0.998	0.000
H66 Suppurative and unspecified otitis media	0.000	0.998	0.002
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.002	0.998	0.000
F33.3 Recurrent depressive disorder, current episode severe with psychotic symptoms	0.002	0.998	0.000
W18.5 Trade and service area	0.002	0.998	0.000
W18.1 Residential institution	0.002	0.998	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.002	0.998	0.000
H74.0 Tympanosclerosis	0.000	0.998	0.002
J40 Bronchitis, not specified as acute or chronic	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
S02.2 Fracture of nasal bones	0.000	0.998	0.002
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.0 Penicillins	0.002	0.998	0.000
D86.3 Sarcoidosis of skin	0.000	0.998	0.002
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.998	0.002
S22.30 Fracture of rib (closed)	0.002	0.998	0.000
G82 Paraplegia and tetraplegia	0.002	0.998	0.000
W18 Other fall on same level	0.002	0.998	0.000
F34.9 Persistent mood [affective] disorder, unspecified	0.002	0.998	0.000
F34.8 Other persistent mood [affective] disorders	0.002	0.998	0.000
F34.0 Cyclothymia	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
D37.4 Colon	0.000	0.998	0.002
F30.8 Other manic episodes	0.002	0.998	0.000
F30.1 Mania without psychotic symptoms	0.002	0.998	0.000
N75.0 Cyst of Bartholin's gland	0.002	0.998	0.000
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.998	0.002
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
S22.40 Multiple fractures of ribs (closed)	0.002	0.998	0.000
F10.2 Dependence syndrome	0.000	0.998	0.002
F30.9 Manic episode, unspecified	0.001	0.998	0.000
M13.97 Arthritis, unspecified (Ankle and foot)	0.000	0.998	0.002
F30.2 Mania with psychotic symptoms	0.001	0.998	0.000
I30.9 Acute pericarditis, unspecified	0.000	0.998	0.002
F30.0 Hypomania	0.001	0.998	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.998	0.002
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
D67 Hereditary factor IX deficiency	0.001	0.998	0.000
H66.4 Suppurative otitis media, unspecified	0.000	0.998	0.001
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.998	0.001
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.998	0.001
H66.0 Acute suppurative otitis media	0.000	0.998	0.001
Y40.8 Other systemic antibiotics	0.001	0.998	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.998	0.002
F34.1 Dysthymia	0.001	0.998	0.000
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
S02.21 Fracture of nasal bones (open)	0.000	0.998	0.001
D21.5 Connective and other soft tissue of pelvis	0.002	0.998	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.002	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.001	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.998	0.000
K83 Other diseases of biliary tract	0.000	0.998	0.002
T51-T65 Toxic effects of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
F32.8 Other depressive episodes	0.002	0.998	0.000
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.998	0.001
K83.9 Disease of biliary tract, unspecified	0.000	0.998	0.001
K83.1 Obstruction of bile duct	0.000	0.998	0.002
W18.9 Unspecified place	0.001	0.998	0.000
W18.8 Other specified place	0.001	0.998	0.000
W18.4 Street and highway	0.001	0.998	0.000
W18.2 School, other institution and public administrative area	0.001	0.998	0.000
W18.0 Home	0.001	0.998	0.000
W18.7 Farm	0.001	0.998	0.000
W18.6 Industrial and construction area	0.001	0.998	0.000
G82.4 Spastic tetraplegia	0.001	0.998	0.000
G82.3 Flaccid tetraplegia	0.001	0.998	0.000
G82.0 Flaccid paraplegia	0.001	0.998	0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.001	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.001	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
M81.90 Osteoporosis, unspecified (Multiple sites)	0.000	0.998	0.002
S62.20 Fracture of first metacarpal bone (closed)	0.001	0.998	0.000
H61.2 Impacted cerumen	0.000	0.998	0.002
H66.3 Other chronic suppurative otitis media	0.000	0.998	0.001
Q51.8 Other congenital malformations of uterus and cervix	0.001	0.998	0.000
Z82.3 Family history of stroke	0.000	0.998	0.002
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.998	0.002
D21.4 Connective and other soft tissue of abdomen	0.001	0.998	0.000
G82.1 Spastic paraplegia	0.001	0.998	0.000
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.998	0.001
H04.1 Other disorders of lachrymal gland	0.000	0.999	0.001
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.999	0.000
Q51.2 Other doubling of uterus	0.001	0.999	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.001	0.999	0.000
T58 Toxic effect of carbon monoxide	0.000	0.999	0.001
Y88 Sequelae of surgical and medical care as external cause	0.000	0.999	0.001
D21 Other benign neoplasms of connective and other soft tissue	0.001	0.999	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.999	0.001
M88.90 Paget's disease of bone, unspecified (Multiple sites)	0.001	0.999	0.000
O80.0 Spontaneous vertex delivery	0.001	0.999	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.001	0.999	0.000
K61 Abscess of anal and rectal regions	0.001	0.999	0.000
J95.0 Tracheostomy malfunction	0.001	0.999	0.000
K83.5 Biliary cyst	0.000	0.999	0.001
K83.4 Spasm of sphincter of Oddi	0.000	0.999	0.001
K83.3 Fistula of bile duct	0.000	0.999	0.001
K83.2 Perforation of bile duct	0.000	0.999	0.001
T65 Toxic effect of other and unspecified substances	0.000	0.999	0.001
T63 Toxic effect of contact with venomous animals	0.000	0.999	0.001
T62 Toxic effect of other noxious substances eaten as food	0.000	0.999	0.001
T61 Toxic effect of noxious substances eaten as seafood	0.000	0.999	0.001
T60 Toxic effect of pesticides	0.000	0.999	0.001
T57 Toxic effect of other inorganic substances	0.000	0.999	0.001
T54 Toxic effect of corrosive substances	0.000	0.999	0.001
T53 Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbone	0.000	0.999	0.001
T52 Toxic effect of organic solvents	0.000	0.999	0.001
T64 Toxic effect of aflatoxin and other mycotoxin food contaminants	0.000	0.999	0.001
T55 Toxic effect of soaps and detergents	0.000	0.999	0.001
W18.09 Other fall on same level: Home: During unspecified activity	0.001	0.999	0.000
W18.04 Other fall on same level, Home , While resting, sleeping, eating or engaging in other vital activities	0.001	0.999	0.000
W18.22 Other fall on same level; School, other institution and public administrative area; While working for income	0.001	0.999	0.000
W18.49 Other fall on same level; Street and highway; During unspecified activity	0.001	0.999	0.000
W18.48 Other fall on same level; Street and highway; While engaged in other specified activities	0.001	0.999	0.000
W18.89 Other fall on same level; Other specified places; During unspecified activity	0.001	0.999	0.000
W18.99 Other fall on same level; Unspecified place; During unspecified activity	0.001	0.999	0.000
W18.93 Other fall on same level; Unspecified place; While engaged in other types of work	0.001	0.999	0.000
A04.8 Other specified bacterial intestinal infections	0.000	0.999	0.001
Y41.5 Antiviral drugs	0.001	0.999	0.000
Y41.1 Antimycobacterial drugs	0.001	0.999	0.000
Y46.2 Hydantoin derivatives	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
K61.1 Rectal abscess	0.001	0.999	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.001	0.999	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.999	0.001
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.999	0.001
D89.3 Immune reconstitution syndrome	0.000	0.999	0.001
D89.1 Cryoglobulinaemia	0.000	0.999	0.001
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.999	0.001
R73.9 Hyperglycaemia, unspecified	0.001	0.999	0.000
S72.4 Fracture of lower end of femur	0.000	0.999	0.001
T56 Toxic effect of metals	0.000	0.999	0.001
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.001	0.999	0.000
T90.4 Sequelae of injury of eye and orbit	0.001	0.999	0.000
Q51 Congenital malformations of uterus and cervix	0.001	0.999	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.001	0.999	0.000
H61.8 Other specified disorders of external ear	0.000	0.999	0.001
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified	0.001	0.999	0.000
T81.3 Disruption of operation wound, not elsewhere classified	0.000	0.999	0.001
Y54.8 Agents affecting uric acid metabolism	0.001	0.999	0.000
Y88.2 Sequelae of adverse incidents associated with medical devices in diagnostic and therapeutic use	0.000	0.999	0.001
Y88.1 Sequelae of misadventures to patients during surgical and medical procedures	0.000	0.999	0.001
Y88.0 Sequelae of adverse effects caused by drugs, medicaments and biological substances in therapeutic use	0.000	0.999	0.001
Z00.0 General medical examination	0.001	0.999	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
D21.9 Connective and other soft tissue, unspecified	0.001	0.999	0.000
D21.6 Connective and other soft tissue of trunk, unspecified	0.001	0.999	0.000
D21.3 Connective and other soft tissue of thorax	0.001	0.999	0.000
H74.1 Adhesive middle ear disease	0.000	0.999	0.001
M25.0 Haemarthrosis	0.001	0.999	0.000
Y46.4 Iminostilbenes	0.001	0.999	0.000
T59 Toxic effect of other gases, fumes and vapours	0.000	0.999	0.001
D80-D89 Certain disorders involving the immune mechanism	0.000	0.999	0.001
K61.4 Intrasphincteric abscess	0.001	0.999	0.000
K61.2 Anorectal abscess	0.001	0.999	0.000
Z82.6 Family history of arthritis and other diseases of the musculoskeletal system and connective tissue	0.000	0.999	0.001
M07.69 Other enteropathic arthropathies (Site unspecified)	0.001	0.999	0.000
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.999	0.001
F00.9 Dementia in Alzheimer's disease, unspecified	0.001	0.999	0.000
H61.0 Perichondritis of external ear	0.000	0.999	0.001
M22.9 Disorder of patella, unspecified	0.001	0.999	0.000
M22.8 Other disorders of patella	0.001	0.999	0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system	0.001	0.999	0.000
T52.9 Organic solvent, unspecified	0.000	0.999	0.001
T52.8 Other organic solvents	0.000	0.999	0.001
T52.4 Ketones	0.000	0.999	0.001
T52.3 Glycols	0.000	0.999	0.001
T52.2 Homologues of benzene	0.000	0.999	0.001
T52.1 Benzene	0.000	0.999	0.001
T52.0 Petroleum products	0.000	0.999	0.001
T53.9 Halogen derivative of aliphatic and aromatic hydrocarbons, unspecified	0.000	0.999	0.001
T53.7 Other halogen derivatives of aromatic hydrocarbons	0.000	0.999	0.001
T53.6 Other halogen derivatives of aliphatic hydrocarbons	0.000	0.999	0.001
T53.5 Chlorofluorocarbons	0.000	0.999	0.001
T53.4 Dichloromethane	0.000	0.999	0.001
T53.3 Tetrachloroethylene	0.000	0.999	0.001
T53.2 Trichloroethylene	0.000	0.999	0.001
T53.1 Chloroform	0.000	0.999	0.001
T53.0 Carbon tetrachloride	0.000	0.999	0.001
T54.9 Corrosive substance, unspecified	0.000	0.999	0.001
T54.3 Corrosive alkalis and alklali-like substances	0.000	0.999	0.001
T54.2 Corrosive acids and acid-like substances	0.000	0.999	0.001
T54.1 Other corrosive organic compounds	0.000	0.999	0.001
T54.0 Phenol and phenol homologues	0.000	0.999	0.001
T57.9 Inorganic substance, unspecified	0.000	0.999	0.001
T57.8 Other specified inorganic substances	0.000	0.999	0.001
T57.3 Hydrogen cyanide	0.000	0.999	0.001
T57.2 Manganese and its compounds	0.000	0.999	0.001
T57.1 Phosphorus and its compounds	0.000	0.999	0.001
T57.0 Arsenic and its compounds	0.000	0.999	0.001
T60.9 Pesticide, unspecified	0.000	0.999	0.001
T60.8 Other pesticides	0.000	0.999	0.001
T60.4 Rodenticides	0.000	0.999	0.001
T60.3 Herbicides and fungicides	0.000	0.999	0.001
T60.2 Other insecticides	0.000	0.999	0.001
T60.1 Halogenated insecticides	0.000	0.999	0.001
T60.0 Organophosphate and carbamate insecticides	0.000	0.999	0.001
T61.9 Toxic effect of unspecified seafood	0.000	0.999	0.001
T61.8 Toxic effect of other seafoods	0.000	0.999	0.001
T61.2 Other fish and shellfish poisoning	0.000	0.999	0.001
T61.1 Scombroid fish poisoning	0.000	0.999	0.001
T61.0 Ciguatera fish poisoning	0.000	0.999	0.001
T62.9 Noxious substance eaten as food, unspecified	0.000	0.999	0.001
T62.8 Other specified noxious substances eaten as food	0.000	0.999	0.001
T62.2 Other ingested (parts of) plant(s)	0.000	0.999	0.001
T62.1 Ingested berries	0.000	0.999	0.001
T62.0 Ingested mushrooms	0.000	0.999	0.001
T63.9 Toxic effect of contact with unspecified venomous animal	0.000	0.999	0.001
T63.8 Toxic effect of contact with other venomous animals	0.000	0.999	0.001
T63.6 Toxic effect of contact with other marine animals	0.000	0.999	0.001
T63.5 Toxic effect of contact with fish	0.000	0.999	0.001
T63.3 Venom of spider	0.000	0.999	0.001
T63.2 Venom of scorpion	0.000	0.999	0.001
T63.1 Venom of other reptiles	0.000	0.999	0.001
T63.0 Snake venom	0.000	0.999	0.001
T65.9 Toxic effect of unspecified substance	0.000	0.999	0.001
T65.8 Toxic effect of other specified substances	0.000	0.999	0.001
T65.6 Paints and dyes, not elsewhere classified	0.000	0.999	0.001
T65.5 Nitroglycerin and other nitric acids and esters	0.000	0.999	0.001
T65.4 Carbon disulphide	0.000	0.999	0.001
T65.3 Nitroderivatives and aminoderivatives of benzene and its homologues	0.000	0.999	0.001
T65.2 Tobacco and nicotine	0.000	0.999	0.001
T65.1 Strychnine and its salts	0.000	0.999	0.001
T65.0 Cyanides	0.000	0.999	0.001
Y46.8 Antispasticity drugs	0.001	0.999	0.000
Y46.7 Anti-Parkinsonism drugs	0.001	0.999	0.000
Y46.6 Other and unspecified antiepileptics	0.001	0.999	0.000
Y46.5 Valproic acid	0.001	0.999	0.000
Y46.3 Deoxybarbiturates	0.001	0.999	0.000
Y46.1 Oxazolidinediones	0.001	0.999	0.000
Y46.0 Succinimides	0.001	0.999	0.000
Z50.9 Care involving use of rehabilitation procedure, unspecified	0.001	0.999	0.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.999	0.001
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.001	0.999	0.000
Q51.3 Bicornate uterus	0.001	0.999	0.000
S22.3 Fracture of rib	0.001	0.999	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.999	0.001
H61 Other disorders of external ear	0.000	0.999	0.001
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
S72.41 Fracture of lower end of femur (open)	0.000	0.999	0.001
C45.0 Mesothelioma of pleura	0.001	0.999	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.999	0.001
T56.9 Metal, unspecified	0.000	0.999	0.001
T56.7 Beryllium and its compounds	0.000	0.999	0.001
T56.6 Tin and its compounds	0.000	0.999	0.001
T56.5 Zinc and its compounds	0.000	0.999	0.001
T56.4 Copper and its compounds	0.000	0.999	0.001
T56.3 Cadmium and its compounds	0.000	0.999	0.001
T56.2 Chromium and its compounds	0.000	0.999	0.001
T56.1 Mercury and its compounds	0.000	0.999	0.001
T56.0 Lead and its compounds	0.000	0.999	0.001
T63.4 Venom of other arthropods	0.000	0.999	0.001
Z50.2 Alcohol rehabilitation	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
E21.0 Primary hyperparathyroidism	0.001	0.999	0.000
H74.4 Polyp of middle ear	0.000	0.999	0.001
K65.9 Peritonitis, unspecified	0.000	0.999	0.001
Q51.9 Congenital malformation of uterus and cervix, unspecified	0.001	0.999	0.000
Q51.7 Congenital fistulae between uterus and digestive and urinary tracts	0.001	0.999	0.000
Q51.6 Embryonic cyst of cervix	0.001	0.999	0.000
Q51.5 Agenesis and aplasia of cervix	0.001	0.999	0.000
Q51.4 Unicornate uterus	0.001	0.999	0.000
Q51.1 Doubling of uterus with doubling of cervix and vagina	0.001	0.999	0.000
Q51.0 Agenesis and aplasia of uterus	0.001	0.999	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.999	0.000
Y41.4 Anthelminthics	0.001	0.999	0.000
Y41.3 Other antiprotozoal drugs	0.001	0.999	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.001	0.999	0.000
Y41.0 Sulphonamides	0.001	0.999	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.001	0.999	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.999	0.000
Y54.9 Mineral salts, not elsewhere classified	0.001	0.999	0.000
Y54.7 Agents affecting calcification	0.001	0.999	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.001	0.999	0.000
Y54.4 Loop [high-ceiling] diuretics	0.001	0.999	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.001	0.999	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.001	0.999	0.000
Y54.0 Mineralocorticoids	0.001	0.999	0.000
Z96.8 Presence of other specified functional implants	0.001	0.999	0.000
M25.09 Haemarthrosis (Site unspecified)	0.001	0.999	0.000
M25.08 Haemarthrosis (Other)	0.001	0.999	0.000
M25.07 Haemarthrosis (Ankle and foot)	0.001	0.999	0.000
M25.05 Haemarthrosis (Pelvic region and thigh)	0.001	0.999	0.000
M25.04 Haemarthrosis (Hand)	0.001	0.999	0.000
M25.03 Haemarthrosis (Forearm)	0.001	0.999	0.000
M25.02 Haemarthrosis (Upper arm)	0.001	0.999	0.000
M25.01 Haemarthrosis (Shoulder region)	0.001	0.999	0.000
M25.00 Haemarthrosis (Multiple sites)	0.001	0.999	0.000
D47.2 Monoclonal gammopathy	0.000	0.999	0.001
H61.1 Non-infective disorders of pinna	0.000	0.999	0.001
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.999	0.001
K14.0 Glossitis	0.000	0.999	0.001
K83.0 Cholangitis	0.000	0.999	0.001
M75.3 Calcific tendinitis of shoulder	0.001	0.999	0.000
S22.4 Multiple fractures of ribs	0.001	0.999	0.000
T59.9 Gases, fumes and vapours, unspecified	0.000	0.999	0.001
T59.7 Carbon dioxide	0.000	0.999	0.001
T59.6 Hydrogen sulphide	0.000	0.999	0.001
T59.5 Fluorine gas and hydrogen fluoride	0.000	0.999	0.001
T59.4 Chlorine gas	0.000	0.999	0.001
T59.3 Lachrymogenic gas	0.000	0.999	0.001
T59.2 Formaldehyde	0.000	0.999	0.001
T59.1 Sulphur dioxide	0.000	0.999	0.001
T59.0 Nitrogen oxides	0.000	0.999	0.001
Y42.5 Other oestrogens and progestogens	0.001	0.999	0.000
Y47.1 Benzodiazepines	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
D83 Common variable immunodeficiency	0.000	0.999	0.001
D82 Immunodeficiency associated with other major defects	0.000	0.999	0.001
D81 Combined immunodeficiencies	0.000	0.999	0.001
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.001	0.999	0.000
D47.1 Chronic myeloproliferative disease	0.000	0.999	0.001
I77.8 Other specified disorders of arteries and arterioles	0.000	0.999	0.001
T56.8 Other metals	0.000	0.999	0.001
S22.31 Fracture of rib (open)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations